Danaher agrees to acquire UK’s Abcam for $5.7bn
Abcam will operate as a standalone company within the Life Sciences segment of Danaher.
29 August 2023
29 August 2023
Abcam will operate as a standalone company within the Life Sciences segment of Danaher.
The therapy did not improve overall survival rate, but Novacure still highlights promise after exploratory sub-analysis.
The additions will bolster UKCA certification capacity despite CE-marking still being allowed for device submissions to the British market.
The 12-week Wysa app trial showed it can improve mood, sleep and overall well-being for NHS staff.
The Withings smart scale gains FDA clearance for the detection of atrial fibrillation using a 6-Lead electrocardiogram.
The trial will assess accessible interventions for cognitive dysfunction linked to long Covid.
The image-guidance system leverages advanced camera-based technology, along with machine-vision algorithms.
Using a blunted tip insertion device, the biodegradable spacer can be deployed through a rapid and minimally invasive procedure.
Enter the Excellence Awards today! This program offers multiple benefits, such as gaining visibility among the market, your employees, and prospective clients for your achievement. To learn more about benefits, entry details, and available marketing packages, download the Research Guide.
Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.
Give your business an edge with our leading industry insights.